FDA approves Xalkori (crizotinib) for treatment of ROS1-positive non-small cell lung cancer. Here’s how American Cancer Society research contributed.
Lung Cancer Research News
The identification of 4 new types of genetic mutations in the most common form of lung cancer could open the door for targeted treatment options for many more patients.
Newer drugs for an aggressive type of lung cancer tend to fail over time. A Society grant has helped one researcher lay the groundwork for better treatments.
The lung cancer mortality rate among women is increasing in many countries, according to a study by American Cancer Society researchers, published May 16 in the journal Cancer Epidemiology, Biomarkers, & Prevention.
An ACS grantee is among the scientists that pinpointed the most prominent cell of origin for the most common type of lung cancer. Now a new molecular profiling technique is giving him a never-before-seen-look at the cells of concern. What he's learning could lead to treatments that target the specific origin of adenocarcinoma.
Researchers at the University of Alabama at Birmingham School of Medicine have recently discovered a new, non-coding gene that may play a key role in causing lung cancer. Read more here.
More than 35 of the top lung cancer researchers in the United States, dubbed the lung cancer “Dream Team,” are coming together to work on one of the most difficult-to-treat lung cancers – those that have a mutation in a gene called KRAS.
A new report, published in CA: A Cancer Journal for Clinicians, highlights the link between silica and lung cancer. The paper, authored by researchers from the American Cancer Society and Emory University, reviewed recent studies that “provide new information about silica and lung cancer.” They note that the findings underscore what more than 100 other studies conducted to date have shown – that there is “strong and consistent evidence that silica exposure increases lung cancer risk.”
In the past, cancer research and fundraising often focused on a specific cancer type, such as breast cancer or lymphoma. Today, research increasingly shows that the next breakthroughs are more likely to occur in unexpected places.
Finding lung cancer early—or better yet, preventing it—among underserved minorities is the goal of American Cancer Society-funded researcher Sanja Percac-Lima, M.D., Ph.D., who will use patient navigators to help patients quit smoking and get screened.
Africa is poised to become the “future epicenter of the tobacco epidemic,” according to a new analysis from the American Cancer Society. It warns that the number of adults in Africa who smoke could increase to 572 million by 2100, from 77 million today, unless leaders take steps to curb current trends.
Discovering a new use for existing drugs is the goal of American Cancer Society-funded researcher Curtis Chong, M.D., Ph.D., who is searching for a targeted agent that can treat drug-resistant lung cancer. Read more here.
The Lung Cancer Dream Team is specifically focused on a difficult-to-treat lung cancer with a common gene mutation called KRAS, which occurs in 20-30% of lung cancers. Learn more here.
Smoking may be linked to more diseases – and more deaths – than previously estimated, according to a study led by American Cancer Society researchers and published online in the New England Journal of Medicine. Learn more here.
The news that the International Agency for Research on Cancer (IARC) now deems air pollution as a leading cause of lung cancer has many in the research community breathing a collective sigh of relief.
Most Americans born into the generations that came after the Baby Boom have gone their entire lives aware that smoking can cause lung cancer. But this fact has not always been well-known – and at one time it wasn’t known at all.